2012. Oxybutynin and tolterodine for treatment of neurogenic detrusor overactivity: a pharmacoeconomic evaluation in the Brazilian context. Brazilian Journal of Pharmaceutical Sciences. 48, 2 (Jun. 2012), 227–236. DOI:https://doi.org/10.1590/S1984-82502012000200006.